Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
21.00
Ask:
24.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

Trading Update

2 Dec 2020 07:00

RNS Number : 1930H
Empresaria Group PLC
02 December 2020
 

2 December 2020

 

Empresaria Group plc

("Empresaria" or the "Group")

 

Trading update

Empresaria, the global specialist staffing group, provides the market with an update on trading for the current financial year ending 31 December 2020.

 

Trading update

 

The Group has continued to demonstrate the financial benefits of its diversity by both geography and sector through the third quarter and the first part of the fourth quarter. Having delivered profits in the first quarter and in the second quarter under extremely challenging circumstances, the Group has continued to progress in the second half delivering profits in each month to date (adjusted profit before tax). Evidence of recovery is being seen across many parts of the Group but this remains slow in some cases and local conditions can be volatile as each location reacts to the ongoing impact from coronavirus.

 

We have continued to accelerate our key operational changes and improvements to ensure the Group is well positioned for the future. Alongside this, we have also progressed our investment in our front office systems including Bullhorn as our core technology platform, and we expect to see further benefits from these changes as we move through 2021. Our stronger together initiatives have continued to be a driver in uniting the Group behind both groupwide projects and localised change.

 

While protecting key investments, cost control has continued to be a priority as we navigate the current environment. Costs have increased over recent months as usage of furlough or similar schemes has reduced and demand has started to return, but this has been managed against increases in net fee income to ensure that the Group is able to deliver improved profit performance.

 

We anticipate that the Group's full year net fee income will be in the range of £52m to £55m and adjusted profit before tax is expected to be in the range of £4.4m to £4.9m. At 30 October adjusted net debt was £11.4m, the increase from 30 June primarily reflecting the repayment of certain tax liabilities which were deferred in the second quarter of 2020 and the impact of increased working capital requirements as net fee income has improved. We would expect net debt to continue to return towards pre-COVID levels as net fee income recovers. Headroom remains strong at £17.6m excluding invoice financing facilities (30 June 2020 £18.1m).

 

The Group expects to provide a further update on trading for the year ended 31 December 2020 in January 2021.

 

- Ends -

 

Enquiries:

Empresaria Group plcRhona Driggs, Chief Executive OfficerTim Anderson, Chief Financial Officer

via Alma PR

N+1 Singer (Nominated Adviser and Broker)Shaun Dobson / James Moat

020 7614 3000

Alma PR (Financial PR)Rebecca Sanders-Hewett

Sam Modlin

David Ison

020 3405 0205empresaria@almapr.com

 

Notes for editors:

§ Empresaria Group plc is a global specialist staffing group offering temporary and contract recruitment, permanent recruitment and offshore recruitment services across 6 sectors: Professional, IT, Healthcare, Property, Construction & Engineering, Commercial and Offshore Recruitment Services.

 

§ Empresaria operates from locations across the world including 4 of the largest staffing markets of the US, Japan, UK and Germany along with a strong presence in Asia Pacific and Latin America.

 

§ Empresaria is listed on AIM under ticker EMR. For more information visit empresaria.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVFLFBBLLBFBL
Date   Source Headline
12th Sep 20239:16 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSPDMR Dealing, Exercise of Share Options
22nd Aug 20237:00 amRNSInterim Results
15th Aug 20237:00 amRNSLaunch of LMA Recruitment in the US
27th Jul 20237:00 amRNSTrading Update and Notice of Results
19th Jun 20238:20 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
23rd May 20231:18 pmRNSResult of AGM
23rd May 20237:00 amRNSTrading Update
16th May 20237:00 amRNSTransaction in Own Shares
2nd May 20236:25 pmRNSDirector/PDMR Shareholding
2nd May 20234:26 pmRNSTransaction in Own Shares
28th Apr 20233:50 pmRNSPDMR Dealing, Exercise of Share Options
26th Apr 20237:00 amRNSCompany LTIP Awards
20th Apr 20237:00 amRNSAnnual Report and Accounts and Notice of AGM
30th Mar 202310:15 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSFinal Results
20th Mar 20233:05 pmRNSNotice of Investor Presentation
20th Feb 20237:00 amRNSAppointment of Independent Non-Executive Director
26th Jan 20237:00 amRNSTrading Update
16th Jan 20237:00 amRNSAppointment of Independent Non-Executive Director
15th Dec 20222:49 pmRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
12th Dec 20227:18 amRNSTransaction in Own Shares
7th Dec 20228:34 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSAppointment of Joint Broker
9th Nov 20228:24 amRNSTransaction in Own Shares
4th Nov 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSDirector/PDMR Shareholding
14th Oct 20223:25 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSCapital Markets Day
6th Oct 20225:10 pmRNSTransaction in Own Shares
4th Oct 20228:13 amRNSTransaction in Own Shares
1st Sep 202212:23 pmRNSTransaction in Own Shares
12th Aug 20227:00 amRNSTransaction in Own Shares
11th Aug 20227:00 amRNSInterim Results
28th Jul 20227:00 amRNSTrading Update and Notice of Results
20th Jun 202210:54 amRNSTransaction in Own Shares
14th Jun 20229:16 amRNSTransaction in Own Shares
7th Jun 202211:44 amRNSDirector/PDMR Shareholding
7th Jun 202211:37 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSBoard Update
18th May 20221:40 pmRNSTransaction in Own Shares
17th May 20228:33 amRNSTransaction in Own Shares
12th May 20224:11 pmRNSResult of AGM
12th May 20223:20 pmRNSTransaction in Own Shares
12th May 20227:00 amRNSTrading Update
11th May 20225:09 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.